Since synaptic dysfunction is evidence of neurodegenerative diseases, such as Parkinson’s disease [15], Alzheimer’s disease [16], and Huntington’s disease [17], promoting the expression of BDNF to repair the synaptic loss could be a strategy for attenuating neurodegenerative disorders. Here, BDNF is linked to early-onset autosomal dominant Alzheimer disease.